TitleTreatment of inflammatory bowel disease (IBD) in dogs and cats
Journal titlePolish Journal of Veterinary Sciences
Divisions of PASNauki Biologiczne i Rolnicze
PublisherUniversity of Warmia and Mazury in Olsztyn ; Polish Academy of Sciences Committee of Veterinary Sciences
ReferencesK Allenspach (2003), Chronic intestinal diseases in the dog: a review, Schweiz Arch Tierheilkd, 5, 209. ; K Allenspach (2006), Pharmacokinetics and Clinical Efficacy of Cyclosporine Treatment of Dogs with Steroid-Refractory Inflammatory Bowel Disease, J Vet Intern Med, 20, 239, doi.org/10.1111/j.1939-1676.2006.tb02852.x ; K Allenspach (2006), Evaluation of gastrointestinal permeability and mucosal absorptive capacity in dogs with chronic entheropathy, Am J Vet Res, 67, 479, doi.org/10.2460/ajvr.67.3.479 ; K Allenspach (2007), Chronic Entheropathies in Dogs: Evaluation of Risk Factors for Negative Outcome, J Vet Intern Med, 21, 700, doi.org/10.1111/j.1939-1676.2007.tb03011.x ; V Bhatia (2005), Stress and the gastrointestinal tract, J Gastroenterol Hepatol, 20, 332, doi.org/10.1111/j.1440-1746.2004.03508.x ; M Craven (2004), Canine inflammatory bowel disease: retrospective analysis of diagnosis and outcome in 80 cases (1995-2002), J Small Anim Pract, 45, 336, doi.org/10.1111/j.1748-5827.2004.tb00245.x ; J Chen (2007), Medicinal importance of fungal β-(1→3),(1→6) glucans, Mycol Res, 3, 635, doi.org/10.1016/j.mycres.2007.02.011 ; M Chrząstowska (2009), Prospects for the use of probiotic bacteria in the treatment of gastrointestinal diseases in dogs, Pol J Vet Sci, 12, 279. ; G Cipolla (2002), Nonsteroidal anti-inflammatory drugs and inflammatory bowel disease: current perspectives, Pharmacol Res, 46, 1, doi.org/10.1016/S1043-6618(02)00033-6 ; M Day (2008), Histopathological Standards for the Diagnosis of Gastrointestinal Inflammation in Endoscopic Biopsy Samples from the Dog and Cat: A Report from the World Small Animal Veterinary Association Gastrointestinal Standardization Group, J Comp Pathol, 138. ; M Day (2004), Immunomodulatory therapy, Veterinary Dermatology, 15, 1. ; J Dennis (1992), Lymphocytic/plasmacytic gastroenteritis in cats: 14 cases (1985-1990), J Am Vet Med Assoc, 200, 1712. ; J Dennis (1993), Lymphocytic/plasmacytic colitis in cats: 14 cases (1985-1990), J Am Vet Med Assoc, 202, 313. ; O Dossin (2009), Chronic diarrhea in cats, Veterinary Focus, 19, 2. ; D Elliott (2006), Nutritional Considerations for the Gastrointestinal Patient, Bull Acad Vet France, 159, 343. ; M Garcia-Sancho (2007), Evaluation of Clinical, Macroscopic, and Histopathologic Response to Treatment in Nonhypoproteinemic Dogs with Lymphocytic-Plasmacytic Enteritis, J Vet Intern Med, 21, 11. ; P Garside (1999), Cytokines in experimental colitis, Clin Exp Immunol, 118, 337, doi.org/10.1046/j.1365-2249.1999.01088.x ; A German (2003), Chronic Intestinal Inflammation and Intestinal Disease In Dogs, J Vet Intern Med, 17, 8, doi.org/10.1111/j.1939-1676.2003.tb01318.x ; A German (2001), Immune cell populations within the duodenal mucosa of dogs with entheropathies, J Vet Intern Med, 15, 14, doi.org/10.1111/j.1939-1676.2001.tb02292.x ; A German (2000), Cytokine mRNA Expression in Mucosal Biopsies from German Shepherd Dogs with Small Intestinal Enteropathies, Dig Dis Sci, 45, 7, doi.org/10.1023/A:1005436721798 ; S Ghosh (2003), Probiotics in inflammatory bowel disease: is it all gut flora modulatioň, Gut, 53, 620, doi.org/10.1136/gut.2003.034249 ; E Hall (2005), Textbook of veterinary internal medicine, 1332. ; E Hall (2007), Mucosal Immunology-Why It's Important; Immune-Mediated Intestinal Disease, null, 19. ; S Hiss (2003), Influence of dietary β-glucan on growth performance, lymphocyte proliferation, specific immune response and haptoglobin plasma concentrations in pigs, J Anim Physiol Anim Nutr, 87, 2, doi.org/10.1046/j.1439-0396.2003.00376.x ; K Hunter Jr. (2002), Preparation of microparticulate β-glucan from saccharomyces cerevisiae for use in immune potentiation, Lett Appl Microbiol, 35, 267, doi.org/10.1046/j.1472-765X.2002.01201.x ; A Jergens (2010), Comparison o oral prednisone and prednisone combined with metronidazole for induction therapy of canine inflammatory bowel disease: a randomized-controlled trial, J Vet Intern Med, 24, 269, doi.org/10.1111/j.1939-1676.2009.0447.x ; A Jergens (2003), A scoring index for disease activity in canine inflammatory bowel disease, J Vet Intern Med, 17, 291, doi.org/10.1111/j.1939-1676.2003.tb02450.x ; A Jergens (2002a), Understanding gastrointestinal inflammation-implications for therapy, J Feline Med Surg, 4, 179, doi.org/10.1053/jfms.2002.0180 ; A Jergens (2002b), Inflammatory bowel disease in the dog and cat, null, 3. ; A Jergens (1999), Inflammatory bowel disease: Current perspectives, Vet Clin North Am Small Anim Pract, 29, 501. ; J Kurtovic (2004), Recent advances in biological therapy for inflammatory bowel disease, Trop Gastroenterol, 25, 9. ; J Li (2005), Effects of β-glucan extracted from Saccharomyces cerevisae on humoral and cellular immunity in weaned pig, Arch Anim Nutr, 59, 303, doi.org/10.1080/17450390500247832 ; A Macpherson (2004), Interactions between commensal intestinal bacteria and the immune system, Nat Rev Immunol, 4, 478, doi.org/10.1038/nri1373 ; T McCann (2007), Evaluation of disease activity markers in dogs with idiopathic inflammatory bowel disease, J Small Anim Pract, 48, 620, doi.org/10.1111/j.1748-5827.2007.00335.x ; K Mitsuyama (2002), Intestinal microflora as a therapeutic target in inflammatory bowel disease, J Gastroenterol, 37, 73. ; R Modigliani (2000), Immunosuppressors for inflammatory bowel disease: how long is long enough?, Inflamm Bowel Dis, 6, 251, doi.org/10.1002/ibd.3780060314 ; M Münster (2006), Assessment of disease severity and outcome of dietary, antibiotic and immunosuppressive interventions by use of the canine IBD activity index in 21 dogs with chronic inflammatory bowel disease, Berl Munch Tierarztl Wochenschr, 119, 493. ; A Pelizon (2005), Immunomodulatory activities associated with β-glucan derived from Saccharomyces cerevisae, Physiol Res, 54, 557. ; R Ransford (2002), Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines, Gut, 51, 536, doi.org/10.1136/gut.51.4.536 ; A Rychlik (2008), Efficacy of different treatment methods in dogs' inflammatory bowel disease, Med Weter, 64, 796. ; A Rychlik (2009), Aktualne problemy w patologii psów i kotów, 71. ; O Salavaggione (2002), Canine red blood cell thiopurine S-methyltransferase: companion animal pharmacogenetics, Pharmacogenetics, 12, 713, doi.org/10.1097/00008571-200212000-00005 ; F Sanchez-Muñoz (2008), Role of cytokines in inflammatory bowel disease, World J Gastroenterol, 14, 4280, doi.org/10.3748/wjg.14.4280 ; W Sandborn (2002), Biologic therapy in inflammatory bowel disease, Gastroenterology, 122, 1592, doi.org/10.1053/gast.2002.33426 ; S Sauter (2007), Cytokine mRNA abundance in intestinal biopsies from dogs with chronic diarrhea, Vet Med, 52, 353. ; S Sauter (2005), Cytokine expression in an ex vivo culture system of duodenal samples from dogs with chronic enteropathies: modulation by probiotic bacteria, Domest Anim Endocrinol, 29, 605, doi.org/10.1016/j.domaniend.2005.04.006 ; A Siwicki (2003), Rola immunomodulatorów pochodzenia naturalnego w zapobieganiu i leczeniu chorób, 7. ; A Stewart (1997), The use of novel formulation of budesonide as an improved treatment over prednisone for inflammatory bowel disease, J Vet Jntern Med, 11, 115. ; K Swanson (2002a), Supplemental fructooligosaccharides and mannanoligosaccharides influence immune function, ileal and total tract nutrientdigestibilities, microbial populations and concentrations of protein catabolites in the large bowel of dogs, J Nutr, 132, 980. ; K Swanson (2002b), Effects of supplemental fructooligosaccharides plus mannanoligosaccharides on immune function and ileal and fecal microbial populations in adult dogs, ArchTierernahr, 56, 309. ; M Szymańska-Czerwińska (2008), Effect of prebiotics on immunological processes in animals, Med Weter, 64, 262. ; J Tumulty (2004), Clinical effects of short-term oral budesonide on the hypothalamic-pituitary-adrenal axis in dogs with inflammatory bowel disease, J Am Anim Hosp Assoc, 40, 120. ; R Wagner (1997), Colonization of congenitally immunodeficient mice with probiotic bacteria. Infect, Immun, 65, 3345. ; R Washabau (2008), Summary of Findings and Reports of the WSAVA Gastrointestinal Standardization Group, null, 60. ; R Wójcik (2007), Influence of β-1,3/1,6-D-glucan on non-specific cellular defence mechanisms in lambs, Med Weter, 63, 84. ; P Xenoulis (2008), Molecular-phylogenetic characterization of microbial communities imbalances in the small intestine of dogs with inflammatory bowel disease, FEMS Microbiol Ecol, 66, 579, doi.org/10.1111/j.1574-6941.2008.00556.x ; J Zentek (2002), Intestinal effects of mannanoligosaccharides, transgalactooligosaccharides, lactose and lactulose in dogs, J Nutr, 132.